FIM
IMGN

Freedom Investment Management’s Immunogen Inc IMGN Stock Holding History

Freedom Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-18,605
Closed -$92.3K – 810
2022
Q4 		$92.3K Sell
18,605
-1,032
-5% -$5.59K 0.01% 687
2022
Q3 		$93.9K Sell
19,637
-832
-4% -$4.39K 0.01% 695
2022
Q2 		$92.1K Buy
20,469
+344
+2% +$1.49K 0.01% 699
2022
Q1 		$96K Buy
+20,125
New +$111K 0.01% 745

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Freedom Investment Management's IMGN Position: Q1 2023 in Review

Freedom Investment Management sold out of Immunogen Inc (IMGN) in Q1 2023, closing a stake of 18,605 shares — an estimated $92.3K sold.

Freedom Investment Management first reported a position in IMGN in Q1 2022 and held it in 4 quarters. The position peaked at $96K in Q1 2022. 190 funds tracked by Wall St. Rank hold IMGN as of Q1 2023.

  • Freedom Investment Management reported no remaining Immunogen Inc position as of Q1 2023 after selling out during the quarter.
  • Freedom Investment Management sold 18,605 Immunogen Inc shares in Q1 2023, an estimated $92.3K.
  • Freedom Investment Management first reported a position in Immunogen Inc in Q1 2022 and held it in 4 quarters.
  • Freedom Investment Management's Immunogen Inc position peaked at $96K in Q1 2022.
  • 190 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2023.

Based on Freedom Investment Management's 13F filing for Q1 2023, filed 15 May 2023.